MarketPulse
A

$ACON

3 articles found
3 positive
0 negative
0 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Aclarion, Inc.

Aclarion Charts Path to Growth With 2026 Reimbursement Push and Clinical Readouts

Aclarion outlines 2026 priorities: pursuing regional insurance reimbursement, releasing CLARITY trial results in Q4 2026, and expanding Nociscan adoption. Strong balance sheet extends to 2028.
ACONACONWbalance sheetchronic low back pain
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aclarion Positions for Growth With Debt-Free Balance Sheet Ahead of ROTH Conference

Aclarion to present at ROTH Conference with debt-free balance sheet, outlining 2026 catalysts for Nociscan expansion in UK and US markets.
ACONACONWbalance sheetchronic low back pain
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Aclarion CEO to Showcase NOCISCAN Platform at LSI USA 2026 Conference

Aclarion CEO to present NOCISCAN platform at LSI USA 2026 investor conference, advancing AI-powered diagnostic technology for chronic low back pain identification.
ACONACONWchronic low back painhealthcare technology